DEXTRANS (AVG M W LESS THAN 100,000)
General Information
| Mainterm | DEXTRANS (AVG M W LESS THAN 100,000) |
| Doc Type | ASP |
| CAS Reg.No.(or other ID) | 9004-54-0 |
| Regnum |
186.1275 |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 4125253 |
| IUPAC Name | 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal |
| InChI | InChI=1S/C18H32O16/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18/h1,5-18,20-30H,2-4H2 |
| InChI Key | FZWBNHMXJMCXLU-UHFFFAOYSA-N |
| Canonical SMILES | C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O |
| Molecular Formula | C18H32O16 |
| Wikipedia | Iron Dextran |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 504.438 |
| Hydrogen Bond Donor Count | 11 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 11 |
| Complexity | 625.0 |
| CACTVS Substructure Key Fingerprint | A A A D c f B 4 P g A A A A A A A A A A A A A A A A A A A A A A A A A k S A A A A A A A A A A A A A A A G g A A C A A A C B S w g A M A C A A A B g A I A A g Q g A I A A A A A A A A A A A F A A A A R E B Y A A A A i Q A A F I A A H A A H K b A x A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
| Topological Polar Surface Area | 277.0 |
| Monoisotopic Mass | 504.169 |
| Exact Mass | 504.169 |
| XLogP3 | None |
| XLogP3-AA | -7.2 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 34 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 14 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB- | 0.5760 |
| Human Intestinal Absorption | HIA- | 0.7737 |
| Caco-2 Permeability | Caco2- | 0.8966 |
| P-glycoprotein Substrate | Substrate | 0.5497 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7288 |
| Non-inhibitor | 0.8644 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8569 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.7044 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8389 |
| CYP450 2D6 Substrate | Non-substrate | 0.8915 |
| CYP450 3A4 Substrate | Non-substrate | 0.6574 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9701 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9683 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9449 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9614 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9577 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9564 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9772 |
| Non-inhibitor | 0.7895 | |
| AMES Toxicity | Non AMES toxic | 0.9026 |
| Carcinogens | Non-carcinogens | 0.9584 |
| Fish Toxicity | Low FHMT | 0.7185 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.6919 |
| Honey Bee Toxicity | High HBT | 0.6406 |
| Biodegradation | Ready biodegradable | 0.5213 |
| Acute Oral Toxicity | IV | 0.5431 |
| Carcinogenicity (Three-class) | Non-required | 0.7324 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -0.1661 | LogS |
| Caco-2 Permeability | -0.6878 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 1.3085 | LD50, mol/kg |
| Fish Toxicity | 2.1539 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | -0.1449 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
| Kingdom | Organic compounds |
|---|---|
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Subclass | Fatty acyl glycosides |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Fatty acyl glycosides of mono- and disaccharides |
| Alternative Parents | |
| Molecular Framework | Aliphatic heteromonocyclic compounds |
| Substituents | Fatty acyl glycoside of mono- or disaccharide - Alkyl glycoside - Disaccharide - Glycosyl compound - O-glycosyl compound - Beta-hydroxy aldehyde - Oxane - Alpha-hydroxyaldehyde - Secondary alcohol - Polyol - Acetal - Organoheterocyclic compound - Oxacycle - Organooxygen compound - Hydrocarbon derivative - Carbonyl group - Organic oxide - Organic oxygen compound - Aldehyde - Alcohol - Primary alcohol - Aliphatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as fatty acyl glycosides of mono- and disaccharides. These are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol. |
From ClassyFire